Is tocilizumab a good therapeutic option for RA and systemic-onset juvenile idiopathic arthritis?

Nat Clin Pract Rheumatol. 2008 Nov;4(11):572-3. doi: 10.1038/ncprheum0900. Epub 2008 Sep 9.

Author

Cem Gabay¹

Affiliation

¹ Division of Rheumatology at University Hospitals of Geneva, Geneva, Switzerland. cem.gabay@hcuge.ch

PMID: 18779846
DOI: 10.1038/ncprheum0900

No abstract available

Publication types

Comment